Last reviewed · How we verify

Placebo - MR Prednisone

Merck KGaA, Darmstadt, Germany · Phase 3 active Small molecule

Placebo - MR Prednisone is a Small molecule drug developed by Merck KGaA, Darmstadt, Germany. It is currently in Phase 3 development for Control arm in Phase 3 clinical trials of modified-release prednisone formulations.

This is a placebo control, not an active drug, and therefore has no pharmacological mechanism of action.

This is a placebo control, not an active drug, and therefore has no pharmacological mechanism of action. Used for Control arm in Phase 3 clinical trials of modified-release prednisone formulations.

At a glance

Generic namePlacebo - MR Prednisone
SponsorMerck KGaA, Darmstadt, Germany
ModalitySmall molecule
Therapeutic areaImmunology/Rheumatology
PhasePhase 3

Mechanism of action

Placebo-MR Prednisone is a modified-release formulation used as a control arm in clinical trials. As a placebo, it contains no active pharmaceutical ingredient and produces therapeutic effects only through the placebo response. It is used to establish efficacy of the actual prednisone formulation being tested.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Placebo - MR Prednisone

What is Placebo - MR Prednisone?

Placebo - MR Prednisone is a Small molecule drug developed by Merck KGaA, Darmstadt, Germany, indicated for Control arm in Phase 3 clinical trials of modified-release prednisone formulations.

How does Placebo - MR Prednisone work?

This is a placebo control, not an active drug, and therefore has no pharmacological mechanism of action.

What is Placebo - MR Prednisone used for?

Placebo - MR Prednisone is indicated for Control arm in Phase 3 clinical trials of modified-release prednisone formulations.

Who makes Placebo - MR Prednisone?

Placebo - MR Prednisone is developed by Merck KGaA, Darmstadt, Germany (see full Merck KGaA, Darmstadt, Germany pipeline at /company/merck-kgaa-darmstadt-germany).

What development phase is Placebo - MR Prednisone in?

Placebo - MR Prednisone is in Phase 3.

Related